Modified Nucleosides
3',4'-Didehydro-3'-deoxycytidine
Quick view. A cytidine nucleoside analogue containing a 3',4'-double bond in the sugar ring, CAS 386264-46-6. CAS 386264-46-6. Catalog target purity: ≥98%. Availability: Inquiry only — contact BX Lab to confirm current availability.
Product profile
3',4'-Didehydro-3'-deoxycytidine is classified as modified nucleosides (Formula C9H11N3O4; molecular weight 225.20 g/mol).
3',4'-Didehydro-3'-deoxycytidine — Reference material for targeted LC-MS research involving ddhC.
For 3',4'-Didehydro-3'-deoxycytidine, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Confirmed or normalized name variants
- ddhC
- 3'-Deoxy-3',4'-didehydrocytidine
Useful catalog search terms
- 386264-46-6
- VQMYKNBUURJYAP-HTRCEHHLSA-N
Physicochemical data
| IUPAC name | 4-amino-1-[(2R,3R)-3-hydroxy-5-(hydroxymethyl)-2,3-dihydrofuran-2-yl]pyrimidin-2-one |
|---|---|
| InChIKey | VQMYKNBUURJYAP-HTRCEHHLSA-N |
| InChI | InChI=1S/C9H11N3O4/c10-7-1-2-12(9(15)11-7)8-6(14)3-5(4-13)16-8/h1-3,6,8,13-14H,4H2,(H2,10,11,15)/t6-,8-/m1/s1 |
| SMILES | C1=CN(C(=O)N=C1N)[C@H]2[C@@H](C=C(O2)CO)O |
| Sugar modification | 3',4'-didehydro; 3'-deoxy |
| Nucleobase | Cytosine |
| PubChem CID | 9813298 |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Modified cytidine nucleoside for identity, analytical, and route-development research.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosyl-L-methionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-01875-(Carboxyhydroxymethyl)uridine
Modified Nucleosides · CAS: 934743-11-0
BX-MN-0719(R)-N6-(2,3-Dihydro-1H-inden-1-yl)adenosine
Modified Nucleosides · CAS: 96392-15-3
BX-MN-01972,2'-Cyclocytidine hydrochloride
Modified Nucleosides · CAS: 10212-25-6
BX-MN-0199N3-Allyluridine
Modified Nucleosides · CAS: 103951-13-9
Frequently asked questions
Can the package size for 3',4'-Didehydro-3'-deoxycytidine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0471 and CAS 386264-46-6, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-relevant literature
The publications below discuss named chemistry or a structural feature represented by this product. They provide scientific context only and are not a BX Lab lot specification or product-performance claim.
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.